Cargando…

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

Cystinosis is a rare genetic disorder characterized by the accumulation of cystine crystals in different tissues and organs causing, among other symptoms, severe ocular manifestations. Cysteamine eye drops are prepared in hospital pharmacy departments to facilitate access to treatment, for which veh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castro-Balado, Ana, Bandín-Vilar, Enrique, Cuartero-Martínez, Andrea, García-Quintanilla, Laura, Hermelo-Vidal, Gonzalo, García-Otero, Xurxo, Rodríguez-Martínez, Lorena, Mateos, Jesús, Hernández-Blanco, Manuela, Aguiar, Pablo, Zarra-Ferro, Irene, González-Barcia, Miguel, Mondelo-García, Cristina, Otero-Espinar, Francisco J., Fernández-Ferreiro, Anxo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607622/ https://www.ncbi.nlm.nih.gov/pubmed/36297629 http://dx.doi.org/10.3390/pharmaceutics14102194

Ejemplares similares

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
por: Castro-Balado, Ana, et al.
Publicado: (2023)

Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
por: Castro-Balado, Ana, et al.
Publicado: (2020)

A Review of Population Pharmacokinetic Analyses of Linezolid
por: Bandín-Vilar, Enrique, et al.
Publicado: (2022)

Ocular Biodistribution Studies Using Molecular Imaging
por: Castro-Balado, Ana, et al.
Publicado: (2019)

Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
por: García-Otero, Xurxo, et al.
Publicado: (2021)

Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review
por: García-Quintanilla, Laura, et al.
Publicado: (2022)

Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model
por: García-Otero, Xurxo, et al.
Publicado: (2021)

Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy
por: Rodríguez-Martínez, Lorena, et al.
Publicado: (2023)

Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019)

Antifungal Combination Eye Drops for Fungal Keratitis Treatment
por: Díaz-Tomé, Victoria, et al.
Publicado: (2022)

Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial
por: Castro-Balado, Ana, et al.
Publicado: (2023)

Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
por: Varela-Fernández, Rubén, et al.
Publicado: (2020)

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
por: Toja-Camba, Francisco José, et al.
Publicado: (2021)

Biopharmaceutical Assessment of Dexamethasone Acetate-Based Hydrogels Combining Hydroxypropyl Cyclodextrins and Polysaccharides for Ocular Delivery
por: Mazet, Roseline, et al.
Publicado: (2020)

Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies’ Determination against ELISA
por: Toja-Camba, Francisco José, et al.
Publicado: (2023)

Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021)

3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease
por: Seoane-Viaño, Iria, et al.
Publicado: (2020)

Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery
por: Varela-Fernández, Rubén, et al.
Publicado: (2022)

Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection
por: Castro-Balado, Ana, et al.
Publicado: (2021)

Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis
por: Luaces-Rodríguez, Andrea, et al.
Publicado: (2018)

Cyclodextrin–polysaccharide-based, in situ-gelled system for ocular antifungal delivery
por: Fernández-Ferreiro, Anxo, et al.
Publicado: (2014)

Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review
por: Busto-Iglesias, Manuel, et al.
Publicado: (2023)

Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2023)

Microbiome in Immune-Mediated Uveitis
por: Rodríguez-Fernández, Carmen Antía, et al.
Publicado: (2022)

Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
por: Makuloluwa, Achini K, et al.
Publicado: (2018)

Solid-state characterization of triamcinolone acetonide nanosuspensiones by X-ray spectroscopy, ATR Fourier transforms infrared spectroscopy and differential scanning calorimetry analysis
por: García-Millán, Eva, et al.
Publicado: (2017)

The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series
por: Biswas, Susmito, et al.
Publicado: (2018)

Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis
por: Peeters, Freya, et al.
Publicado: (2019)

Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops
por: Beck, Ria, et al.
Publicado: (2019)

Physicochemical Properties of Hyaluronic Acid–Based Lubricant Eye Drops
por: Aragona, Pasquale, et al.
Publicado: (2019)

A monoclinic polymorph of cysteamine hydrochloride
por: Ahmad, Saeed, et al.
Publicado: (2009)

Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018)

A Review on the Antimutagenic and Anticancer Effects of Cysteamine
por: Lee, Chun-Man
Publicado: (2023)

Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients
por: Klank, Sabrina, et al.
Publicado: (2023)

Use of Hyaluronic Acid (HA) in Chronic Airway Diseases
por: Máiz Carro, Luis, et al.
Publicado: (2020)

Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation
por: Sánchez-Sánchez, María-Pilar, et al.
Publicado: (2015)

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
por: Bouazza, Naïm, et al.
Publicado: (2011)

The effect of verapamil on cysteamine-induced duodenal ulcer in the rat.
por: Lee, C. K., et al.
Publicado: (1987)

Effects of long-term cysteamine treatment in patients with cystinosis
por: Ariceta, Gema, et al.
Publicado: (2017)

Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases
por: Paul, Bindu D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_biklsh68lmi9oceoff5kn6blu8